The Food and Drug Administration (FDA) has authorized the first covid-19 diagnostic test that can be performed at that the point of care. That means that the test can be done and results known immediately within the facility.
Previously, test results could not be known until several days later. The new diagnostic test delivers results within 45 minutes.
According to a statement issued by the California based CEPHEID, “The test has been designed to operate on any of Cepheid’s more than 23,000 automated GeneXpert® Systems worldwide, with a detection time of approximately 45 minutes.
Additionally, “An accurate test delivered close to the patient can be transformative” and can “help alleviate the pressure” that the COVID-19 outbreak has put on health facilities, David Persing, Cepheid’s chief medical and technology officer, said in a statement. This means that patients will receive their testing in hospitals and at their doctor’s offices.
“People in general are frustrated with the turnaround time. They don’t know their status until days later. Knowing your status quickly … will allow much better decision making” and help doctors choose the best treatment, Persing said in a video on the company’s website.
The test kits will be starting shipping next week. For more information about CEPHEID, Please click on the link below.